Guizhou Sanli PharmaceuticalLtd Management
Management criteria checks 4/4
Guizhou Sanli PharmaceuticalLtd's CEO is Hai Zhang, appointed in Jan 2015, has a tenure of 9.92 years. directly owns 44.67% of the company’s shares, worth CN¥2.45B. The average tenure of the management team and the board of directors is 5.3 years and 5.2 years respectively.
Key information
Hai Zhang
Chief executive officer
CN¥758.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.9yrs |
| CEO ownership | 44.7% |
| Management average tenure | 5.3yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Passed With Ease
Oct 16
Little Excitement Around Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Earnings
Aug 25Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?
Aug 03Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 23Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly
Mar 25Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 06CEO
Hai Zhang (38 yo)
9.9yrs
Tenure
CN¥758,000
Compensation
Mr. Hai Zhang is Chairman & GM of Guizhou Sanli Pharmaceutical Co.,Ltd from January 2015.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 9.9yrs | CN¥758.00k | 44.67% CN¥ 2.5b | |
| CFO, Head of Accounting & Director | 9.9yrs | CN¥462.30k | 0.065% CN¥ 3.6m | |
| Deputy General Manager | 3.6yrs | CN¥465.60k | 0.019% CN¥ 1.0m | |
| Deputy General Manager | 6.8yrs | CN¥461.80k | 0.23% CN¥ 12.8m | |
| Deputy General Manager | 3.9yrs | CN¥537.00k | 0.060% CN¥ 3.3m | |
| Vice Chairman & Board Secretary | 6.8yrs | CN¥578.20k | 0.12% CN¥ 6.4m | |
| Chairman of the Supervisory Board & Manager of Human Resources Department | 3.6yrs | CN¥314.20k | no data | |
| Supervisor & Business Manager | 2.1yrs | CN¥300.30k | no data |
5.3yrs
Average Tenure
38.5yo
Average Age
Experienced Management: 603439's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 9.9yrs | CN¥758.00k | 44.67% CN¥ 2.5b | |
| CFO, Head of Accounting & Director | 9.9yrs | CN¥462.30k | 0.065% CN¥ 3.6m | |
| Vice Chairman & Board Secretary | 6.8yrs | CN¥578.20k | 0.12% CN¥ 6.4m | |
| Chairman of the Supervisory Board & Manager of Human Resources Department | 3.6yrs | CN¥314.20k | no data | |
| Supervisor & Business Manager | 2.1yrs | CN¥300.30k | no data | |
| Director | 9.9yrs | no data | 5.48% CN¥ 300.8m | |
| Independent Director | 2yrs | CN¥60.00k | no data | |
| Independent Director | 2yrs | CN¥60.00k | no data |
5.2yrs
Average Tenure
45yo
Average Age
Experienced Board: 603439's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 22:00 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guizhou Sanli Pharmaceutical Co.,Ltd is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Ye | Ping An Securities Co. Ltd. |
| Mengmeng Han | Ping An Securities Co. Ltd. |
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |